Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate

A J Tipping, S Baluch, D J Barnes, D R Veach, B M Clarkson, W G Bornmann, F X Mahon, J M Goldman, J V Melo*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate'. Together they form a unique fingerprint.

Medicine & Life Sciences